ArticleScientific reports2026
Analysis of clinical and pathological characteristics of classic adrenocortical carcinoma.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Adrenocortical carcinoma (ACC) is a rare malignancy; however, its specific characteristics within the Chinese population remain poorly characterized. This study investigates the clinical and pathological characteristics of classic adrenocortical carcinoma in a Chinese cohort to improve understanding of the disease and inform management strategies. We retrospectively investigated the clinical and pathological features of 138 classic ACC patients treated at Peking Union Medical College Hospital from January, 1984 to January, 2024. The gene expression profile of 79 ACC patients with survival data was downloaded from the TCGA database. P < 0.05 was considered statistically significant. We found that classic ACC was more common in women than in men, and the majority of classic ACC patients were diagnosed over 40. The tumor exhibited a slight right-sided laterality, with the incidence on the right side being 1.28 times that of the left. The median tumor diameter was 9.05 cm at diagnosis. We revealed that the Ki-67 index of most patients was over than 5% and the median of Ki-67 index was 20%. The majority of classic ACC patients were categorized into ENSAT stage II (47.1%) and III (27.54%) at diagnosis. In addition, classic ACC patients with advanced stage tended to get higher levels of Ki-67 index (P = 0.002). Patients with higher Ki-67 index (P = 0.036) and Ki-67 gene expression (P < 0.001) had worse overall survival rate. Pathway analysis in patients with high MKI67 expression revealed an enrichment of genes associated with cell cycle regulation and p53 signaling, suggesting a potential link between high proliferative activity and these molecular pathways. In conclusion, this study provides valuable insights into the clinical and pathological profiles of ACC in the Chinese population, facilitating better diagnostic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.